Latest filing published 27 Aug 2026 for Monopar Therapeutics, €6.
Filing timeline
BuySaleInsider track record
Patrice Rioux: trading record in brief
Patrice Rioux is a declared insider at 2 companies; the most frequent names are Monopar Therapeutics and Raptor Pharmaceutical Corp. Between 13 April 2012 and 26 August 2026, the trades on record add up to 5 filings.
On the market, this insider has only sold: 1 sale, €95 in total. Besides market trades, the filings include 4 option exercises. Since January 2026: no purchases and 1 sale on the market.
The newest entry dates from 27 August 2026: an option exercise of €6, in Monopar Therapeutics. The median gap between trade and publication is zero days: most filings appear on the same day. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Patrice Rioux
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,380 shares@ US$0.0050.0000% mcap5.8% of flowCommon StockSEC:0001437749-26-029121:0
- 1 shares@ US$111.260.0000% mcap94.2% of flowCommon StockSEC:0001437749-26-029121:1
- 18,333 shares@ US$6.00Common StockSEC:0001654954-19-013406:0
- 100 shares0Common StockSEC:0001654954-19-013406:1
- 25,497 shares@ US$0.85Common StockSEC:0001140361-12-020443:0
5 of 5 declarations
